Raptiva Side Effects Attorney

Raptiva Side Effects Lawsuit Attorney

Raptiva Side Effects Lawsuit Attorney

              Raptiva, a drug that is no longer available in the U.S. because of its association with Progressive Multifocal Leukoencephalopathy (PML), is an injectable drug that is used to treat moderate and severe plaque psoriasis and who are candidates for systemic therapy or phototherapy in adults 18 years of age or older.

              Progressive Multifocal Leukoencephalopathy is a serious and frequently fatal brain infection that is often acquired during childhood. It is caused by a polyomavirus that attacks the brain and the central nervous system. Most adult patients do not develop PMD but are infected with the JC virus. Patients who survive PML usually are permanently disabled.       

PML symptoms include:
  • Problems with vision
  • memory loss
  • loss of coordination

 

Recommended dosage for Raptiva is a single conditioning dose of 0.7mg/kg followed by a weekly subcutaneous dose of 1mg/kg. The maximum Raptiva dose should not exceed a total of 200mg. Doses should be administered under the supervision of a physician unless it is deemed appropriate for self-injection with a medical follow-up after proper training in the preparation and injection is administered. 

              Raptiva should be inspected visually before administration for the presence of particulate matter and discoloration and should be administered using a disposable, sterile syringe and the needles that are provided. The product should not be used if discoloration or particulate matter is eminent.
              Approved by the FDA in 2003, Raptiva actually blocks the establishment of certain immune cells referred to as T-cells and by blocking the passage of those cells into the skin. This, however, can increase the risk of dangerous infections in patients because it simply suppresses the body’s natural defense system.
              Raptiva is supplied for subcutaneous injection in a one-use glass vial. It is a white to off-white, sterile, Iyophilized powder. Raptiva is designed to deliver 125mg of efalizumab in 1.25mL. The carton of Raptiva contains four trays of which contain one single-use vial that is intended to deliver 1215mg of efalizumab, a prefilled single-use diluents syringe consisting of 1.3mL of sterile water for injection, two alcohol prep pads, two25 gauge × 5/8 inch needles, and patient information insert along with a package insert.
              The side effects lawsuit and adverse reactions associated with Raptiva are as follows:
  • transverse myelitis
  • bronchiolitis obliterans
  • aseptic meningitis
  • idiopathic hepatitis
  • sialadenitis
  • sensorineural hearing loss
  • Dyspnea
  • Asthma
  • Urticaria
  • Angioedema
  • maculopapular rash
  • dyspnea
  • asthma
  • urticaria
  • angioedema
  • maculopapular rash
  • Headache
  • Infection
  • Chills
  • Nausea
  • Pain
  • Myalgia
  • Flu Syndrome
  • Fever
  • Back pain
  • Acne
  • Side Effects Lawsuit Attorney
  • Raptiva Lawsuit
  • Raptiva Recall Lawyer
Discuss this article in the forums (0 replies).

Ask An Attorney

Do I Have A Lawsuit?
Name(*)

Please enter your name.

Email(*)

Please enter your email address

Phone(*)

Please enter your phone number

City(*)

Please enter your city.

State(*)

Select your state from the menu.

Zip Code(*)

Invalid Input

Have you already hired a lawyer(*)

Do you already have an attorney?

Briefly describe your complaint or legal questions.

Please briefly explain your complaint or legal question.


I understand that submission of contact and case information via this form does not establish nor constitute a contractual attorney-client relationship. An attorney will review this information and contact the submitter to establish a client-law firm relationship.